C. Pison (Grenoble Cedex 9, France), H. Magnussen (Grosshansdorf, Germany)
Use of antidepressive agents in COPD patients: experience in a large Canadian cohort
C. Fortin, H. Chapdelaine, N. Bergeron, C. Poirier (Montreal, Canada)
|   |
Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
P. D. T. Muller, J. A. Neder, C. A. D. A. Viegas (Campo Grande, São Paulo, Brasília, Brazil)
| |
The prevalence of gastroesophageal reflux disease (GERD) in bronchiectasis and COPD
A. Lee, B. Button, L. Denehy, S. Roberts, S. Ellis, R. Stirling, J. Wilson (Melbourne, VIC, Australia)
| |
Aortic pulse wave velocity and myocardium condition in COPD patients
T. Brodskaya, B. Geltser, V. Nevzorova (Vladivostok, Russian Federation)
| |
What is real prevalence of COPD in patients with lung cancer?
S. Wesolowski, M. Franczuk, P. Boros (Warsaw, Poland)
| |
Hospitalisation of COPD patients due to comorbidity
B. Gehrt, R. Maerkedahl, U. M. Weinreich (Viborg, Skive, Denmark)
| |
COPD patients with hypogonadism are more hypoxic and hypercapnic during exacerbation than patients with normal testosterone level
A. Nowinski, D. Kaminski, D. Korzybski, A. Stoklosa, D. Gorecka (Warsaw, Poland)
| |
Erectile dysfunction and relationship with disease parameters in COPD cases
A. Usalan, M. Buyuksirin, G. Polat, G. Tibet (Izmir, Turkey)
| |
Comparative analysis of anxiety, depression and hopeless in patients with COPD and anxious depressive disorders
E. Tupkovic, D. Keser, K. Brigic, E. Turkusic, E. Zukic, E. Jusufovic, A. Nadarevic, F. Petrak (Tuzla, Bosnia And Herzegovina)
| |
COPD and osteoporosis
K. C. Tertemiz, O. Gungor, Y. Cihan, A. Akkoclu (Izmir, Turkey)
| |
The blue bloater phenotype in COPD is associated with metabolic syndrome
F. Flores-Trujillo, A. Ramirez-Venegas, R. J. Hernandez-Zenteno, C. Sanchez-Romero, J. Regalado-Pineda, R. H. Sansores-Martinez (Mexico City DF, Mexico)
| |
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
P. Skyba, Z. Kluchova, P. Joppa, D. Petrasova, A. Molcanyiova, R. Tkacova (Kosice, Slovakia)
| |
Assessment of nutritional status in COPD
J. de Miguel-Diez, A. Castuera, F. Villar-Alvarez, C. Perez, M. J. Chillon-Martin, L. Puente-Maestu (Madrid, Spain)
| |
COPD: different psychology changes in the patients with different nutritive status
K. Gashynova (Dnipropetrovsk, Ukraine)
| |
COPD hospitalizations in obese and normal weight subjects: different outcomes or different BMI‘s?
S. Antoniu, A. Cozorici-Iancu, I. Radu, T. Mihaescu (Iasi, Romania)
| |
Nutritive status and the left ventricular mass (LVM) in patients with COPD
S. Lokshyn, K. Gashynova (Dnipropetrovsk, Ukraine)
| |